Molecular and Cellular Biology, January 2001, p. 39-50, Vol. 21, No. 1
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.1.39-50.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Biochemistry, University of Leicester, Leicester, LE1 7RH,1 and Department of Cancer Medicine, Imperial College School of Medicine, London, W12 0NN,2 United Kingdom
Received 5 June 2000/Returned for modification 12 July 2000/Accepted 28 September 2000
The transcriptional activity of nuclear receptors is mediated by
coactivator proteins, including steroid receptor coactivator 1 (SRC1)
and its homologues and the general coactivators CREB binding protein
(CBP) and p300. SRC1 contains an activation domain (AD1) which
functions via recruitment of CBP and and p300. In this study, we have
used yeast two-hybrid and in vitro interaction-peptide inhibition
experiments to map the AD1 domain of SRC1 to a 35-residue sequence
potentially containing two
-helices. We also define a 72-amino-acid
sequence in CBP necessary for SRC1 binding, designated the SRC1
interaction domain (SID). We show that in contrast to SRC1, direct
binding of CBP to the estrogen receptor is weak, suggesting that SRC1
functions primarily as an adaptor to recruit CBP and p300. In support
of this, we show that the ability of SRC1 to enhance ligand-dependent
nuclear receptor activity in transiently transfected cells is dependent
upon the integrity of the AD1 region. In contrast, the putative histone
acetyltransferase domain, the Per-Arnt-Sim basic helix-loop-helix
domain, the glutamine-rich domain, and AD2 can each be removed without
loss of ligand-induced activity. Remarkably, a construct corresponding
to residues 631 to 970, which contains only the LXXLL motifs and the
AD1 region of SRC1, retained strong coactivator activity in our assays.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|